EORTC seeks to improve the quality of surgery in cancer research by developing a platform to facilitate standardization of surgical techniques and central monitoring of surgical outcomes. This platform is called SURCARE , a collaborative project with the European Society of Surgical Oncology (ESSO) and the Japanese Clinical Oncology Group (JCOG). SURCARE is coordinated by Prof. Serge Evrard (EORTC Board member and ESSO Clinical Research Committee Chair).


  • 1409 CLIMB: evaluates the surgical and long-term outcomes of initially unresectable colorectal  liver metastases to establish thresholds for quality of care within Europe.
  • 1527 DREAM: evaluates the accuracy of diffusion-weighted magnetic resonance imaging in assessing the sites of disappearing metastasis among patients with complex colorectal liver metastases who respond to systemic therapy and use this imaging biomarker for precise surgical planning.
  • 1203 INNOVATION: evaluates the efficacy of the combination of pertuzumab and trastuzumab as a perioperative treatment for gastric cancer; a combined surgical and pathology central review is being performed to ensure quality
  • 1420 BEST OF: evaluates the efficacy of transoral surgery and intensity modulated radiotherapy for early stage oropharyngeal cancer in improving swallowing function; SURCARE is being utilized to implement quality assurance for the surgical arm to complement the RTQA in the radiotherapy arm.